$41.03
1.25%
NYSE, Oct 01, 04:00 pm EDT. Closed.
ISIN
US69380Q1076
Symbol
PACS

PACS Group Target price 2026 - Analyst rating & recommendation

PACS Group Classifications & Recommendation

Buy
92%
Hold
8%

PACS Group Price Target

Target Price $61.20
Price $41.03
Potential
Number of Estimates 8
8 Analysts have issued a price target PACS Group 2027 . The average PACS Group target price is $61.20. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 11 Analysts recommend PACS Group to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the PACS Group stock has an average upside potential 2027 of . Most analysts recommend the PACS Group stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 5.29 5.95
29.32% 12.42%
EBITDA Margin 6.91% 11.27%
72.35% 63.19%
Net Margin 3.62% 6.65%
165.62% 83.62%

8 Analysts have issued a sales forecast PACS Group 2026 . The average PACS Group sales estimate is

$5.9b
unlock
. This is
7.12% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.2b 11.89%
unlock
, the lowest is
$5.7b 2.31%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $5.3b 29.32%
2026
$5.9b 12.42%
unlock
2027
$6.5b 9.37%
unlock
2028
$7.1b 8.86%
unlock

8 Analysts have issued an PACS Group EBITDA forecast 2026. The average PACS Group EBITDA estimate is

$670m
unlock
. This is
40.10% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$701m 46.66%
unlock
, the lowest is
$639m 33.59%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $365m 122.88%
2026
$670m 83.46%
unlock
2027
$722m 7.75%
unlock
2028
$785m 8.68%
unlock

EBITDA Margin

2025 6.91% 72.35%
2026
11.27% 63.19%
unlock
2027
11.10% 1.51%
unlock
2028
11.08% 0.18%
unlock

8 PACS Group Analysts have issued a net profit forecast 2026. The average PACS Group net profit estimate is

$395m
unlock
. This is
46.80% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$416m 54.42%
unlock
, the lowest is
$371m 37.78%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $192m 243.51%
2026
$395m 106.30%
unlock
2027
$438m 10.97%
unlock
2028
$482m 10.01%
unlock

Net Margin

2025 3.62% 165.62%
2026
6.65% 83.62%
unlock
2027
6.74% 1.35%
unlock
2028
6.81% 1.04%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 1.22 2.50
221.05% 104.92%
P/E 16.44
EV/Sales 1.13

8 Analysts have issued a PACS Group forecast for earnings per share. The average PACS Group EPS is

$2.50
unlock
. This is
49.70% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$2.63 57.49%
unlock
, the lowest is
$2.34 40.12%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $1.22 221.05%
2026
$2.50 104.92%
unlock
2027
$2.77 10.80%
unlock
2028
$3.05 10.11%
unlock

P/E ratio

Current
2026
16.44 33.09%
unlock
2027
14.82 9.85%
unlock
2028
13.47 9.11%
unlock

Based on analysts' sales estimates for 2026, the PACS Group stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.21
2026
1.13 6.43%
unlock
2027
1.04 8.57%
unlock
2028
0.95 8.13%
unlock

P/S ratio

Current
2026
1.09 6.64%
unlock
2027
1.00 8.57%
unlock
2028
0.92 8.14%
unlock

Current PACS Group Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JP Morgan
Locked
➜
Locked
Locked Sep 04 2026
Oppenheimer
Locked
➜
Locked
Locked Aug 10 2026
Truist Securities
Locked
➜
Locked
Locked Aug 06 2026
RBC Capital
Locked
➜
Locked
Locked Aug 06 2026
UBS
Locked
➜
Locked
Locked Aug 06 2026
UBS
Locked
➜
Locked
Locked Jul 08 2026
Truist Securities
Locked
➜
Locked
Locked May 18 2026
Analyst Rating Date
Locked
JP Morgan:
Locked
➜
Locked
Sep 04 2026
Locked
Oppenheimer:
Locked
➜
Locked
Aug 10 2026
Locked
Truist Securities:
Locked
➜
Locked
Aug 06 2026
Locked
RBC Capital:
Locked
➜
Locked
Aug 06 2026
Locked
UBS:
Locked
➜
Locked
Aug 06 2026
Locked
UBS:
Locked
➜
Locked
Jul 08 2026
Locked
Truist Securities:
Locked
➜
Locked
May 18 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today